BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7648066)

  • 1. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
    Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
    Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
    J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
    Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
    Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
    Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
    Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
    Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
    Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Perkins AC; Frier M; Wastie ML; Denton G; Price MR; Denley H; Bishop MC
    BJU Int; 2001 Jan; 87(1):39-46. PubMed ID: 11121991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope.
    Perkins AC; Symonds IM; Pimm MV; Price MR; Wastie ML; Symonds EM
    Nucl Med Commun; 1993 Jul; 14(7):578-86. PubMed ID: 8355918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
    Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
    Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer.
    Simms MS; Murray A; Denton G; Scholfield DP; Price MR; Perkins AC; Bishop MC
    Urol Res; 2001 Feb; 29(1):13-9. PubMed ID: 11310209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
    Murray A; Simms MS; Scholfield DP; Vincent RM; Denton G; Bishop MC; Price MR; Perkins AC
    J Nucl Med; 2001 May; 42(5):726-32. PubMed ID: 11337567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
    Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
    Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
    Li N; Yu L; Zhang C
    Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
    Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
    Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin expression by transitional cell carcinomas of the bladder.
    Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
    Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26.
    Boeckmann W; Baum RP; Schuldes H; Kramer W; Hertel A; Baew-Christow T; Hanke P; Jonas D; Hör G
    Br J Cancer Suppl; 1990 Jul; 10():81-4. PubMed ID: 2383485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.